A pragmatic, off-label, randomised controlled trial of variable inhaled corticosteroid dosing by blood eosinophil level and medication adherence digital evaluation in airways disease
Latest Information Update: 08 Aug 2024
At a glance
- Drugs Umeclidinium (Primary) ; Vilanterol/fluticasone furoate (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
Most Recent Events
- 06 Aug 2024 Status changed from recruiting to discontinued.
- 24 Sep 2022 New trial record